Cell models included the SAMHD1-expressing AML cell line THP-1 and its subline, in which the SAMHD1 gene had been disrupted by CRISPR/Cas9 (THP-1- KO). This evidence concerns the gene SAMHD1 and acute myeloid leukemia.